SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech fireworks
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tom pope who wrote (7009)11/1/2018 2:30:33 PM
From: tuck  Read Replies (1) of 7424
 
Trillium (TRIL) up 17% after a major sell off, due to decent data in ASH abstract (competitor SURF is not presenting and is getting whipped). The concern is TRIL will have to finance in the not too distant future - or partner. Meanwhile, competitors - notably FTSV - have programs that are so far showing less side effects than expected. I have followed TRIL and been in and out of it over the last several years, but I've been on the sidelines for a while and will remain so for the time being.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News